New patent for Astrazeneca Ab drug QTERNMET XR

October 7, 2020 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are ten…

The post New patent for Astrazeneca Ab drug QTERNMET XR appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.